Biohaven Pharmaceutical Holding Co Ltd (NASDAQ:BHVN) was down 0.2% during trading on Wednesday after Needham & lowered their price target on the stock from $43.00 to $36.00. Needham & currently has a buy rating on the stock. Biohaven Pharmaceutical Holding Co traded as low as $32.02 and last traded at $33.00. Approximately 185,451 shares changed hands during mid-day trading, an increase of 17% from the average daily volume of 157,870 shares. The stock had previously closed at $33.08.

Other equities analysts also recently issued research reports about the company. BidaskClub downgraded Biohaven Pharmaceutical Holding Co from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, September 20th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $54.00 price target on shares of Biohaven Pharmaceutical Holding Co in a research report on Tuesday, September 12th. Zacks Investment Research upgraded Biohaven Pharmaceutical Holding Co from a “sell” rating to a “hold” rating in a report on Friday, September 8th. Finally, Morgan Stanley boosted their price objective on Biohaven Pharmaceutical Holding Co from $28.00 to $47.00 and gave the stock an “overweight” rating in a research report on Monday, September 25th. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. Biohaven Pharmaceutical Holding Co has an average rating of “Buy” and an average price target of $40.80.

The company has a 50 day moving average price of $35.38 and a 200-day moving average price of $27.66. The company’s market cap is $1.19 billion.

TRADEMARK VIOLATION NOTICE: “Biohaven Pharmaceutical Holding Co Ltd (BHVN) Stock Price Down 0.2% Following Analyst Downgrade” was first reported by Marea Informative and is the sole property of of Marea Informative. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at

About Biohaven Pharmaceutical Holding Co

Biohaven Pharmaceutical Holding Company Ltd. is a United States-based biopharmaceutical company. The Company is engaged in the identification and development of clinical-stage compounds targeting orphan neurologic indications and other neurological pathways. It has a portfolio of multiple late-stage drug candidates.

Receive News & Stock Ratings for Biohaven Pharmaceutical Holding Co Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biohaven Pharmaceutical Holding Co Ltd and related stocks with our FREE daily email newsletter.